Sanfetrinem
Alternative Names: GV 104326Latest Information Update: 31 Aug 1999
At a glance
- Originator GlaxoSmithKline
- Class Antibacterials; Beta-lactams
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections